Literature DB >> 15230637

Enteroviral infection in Greek AIDS patients.

Dimitrios Papaventsis1, Panayotis Markoulatos, Nikolaos Mangafas, Marios Lazanas, Stamatina Levidiotou-Stefanou.   

Abstract

OBJECTIVE: Prolonged intestinal replication of polioviruses has not previously been studied in Greek AIDS patients. The objective of our study was to estimate the prevalence of enteroviral infections in this population.
METHODS: Nineteen stool samples were investigated from 19 different patients. Collection took place at the Hellenic Red Cross Hospital, Athens, Greece, between August and October 2002. Samples were processed as follows: virus isolation was attempted by cell culture using three different cell lines (human epidermoid carcinoma [Hep]-2, rabdomyosarcoma [RD], and mouse cells genetically modified in order to express the polio virus receptor in their cell surface [L20(B)]). An enterovirus-specific reverse transcription (RT)-PCR was then applied. Finally, seroneutralization tests were performed on 11 blood samples taken from a number of the patients who had supplied stool samples.
RESULTS: Samples were negative for enterovirus detection of any serotype on all cell lines. No cytopathic effect was observed. Enterovirus-specific RT-PCR assays were also negative for the detection of enteroviral RNA. Seroneutralization revealed relatively high antibody titers against poliovirus 1 and 2 in three of the eleven blood samples.
CONCLUSIONS: Greek AIDS patients are not vulnerable to enteroviral infections and do not constitute a potential reservoir of poliovirus-prolonged excretion in Greece.

Entities:  

Mesh:

Year:  2004        PMID: 15230637     DOI: 10.1007/bf03260042

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  16 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Treatment of AIDS and HIV-related conditions: 2001.

Authors:  R H Goldschmidt; B J Dong
Journal:  J Am Board Fam Pract       Date:  2001 Jul-Aug

3.  High sequence divergence in the 5' non-coding region of reference Coxsackie B and ECHO viral strains and clinical isolates revealed by restriction fragment length polymorphism analysis.

Authors:  A Georgopoulou; P Markoulatos; N Spyrou; N Vakalis; T A Bei; N C Vamvakopoulos
Journal:  Mol Cell Probes       Date:  2001-12       Impact factor: 2.365

4.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 5.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Isolation of polioviruses and other enteroviruses in south Greece between 1994 and 1998.

Authors:  N Siafakas; A Georgopoulou; P Markoulatos; N Spyrou
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

7.  New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay.

Authors:  I Casas; L Powell; P E Klapper; G M Cleator
Journal:  J Virol Methods       Date:  1995-05       Impact factor: 2.014

8.  Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Authors:  O M Kew; R W Sutter; B K Nottay; M J McDonough; D R Prevots; L Quick; M A Pallansch
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

9.  Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Authors:  S Guillot; V Caro; N Cuervo; E Korotkova; M Combiescu; A Persu; A Aubert-Combiescu; F Delpeyroux; R Crainic
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

10.  Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.

Authors:  R W Ryder; M J Oxtoby; M Mvula; V Batter; E Baende; W Nsa; F Davachi; S Hassig; I Onorato; A Deforest
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.